The Impact of Molecularly Targeted Therapy in Multi-Modality Therapy

摘要: The development of a large number targeted agents has introduced tremendous opportunities as well challenges to the field oncology. Although most show limited single drug potential for cure common solid neoplasms, they can prolong patient survival in selected tumor types and, importantly, enhance existing therapies variety cancers. Improvements have been achieved treatment hematological malignancies, colorectal cancer, renal lung head and neck breast liver cancer. Because these do not cause side effects similar those cytotoxic drugs radiation therapy, their combination with current conventional chemotherapy radiotherapy is usually feasible. How best combine new requires intensive persistent efforts from both clinicians research scientists.